2007
DOI: 10.1038/sj.ejcn.1602777
|View full text |Cite
|
Sign up to set email alerts
|

Effect of intradialytic parenteral nutrition in patients with malnutrition–inflammation complex syndrome on body weight, inflammation, serum lipids and adipocytokines: results from a pilot study

Abstract: Objective: Evaluation of the influence of intradialytic parenteral nutrition (IDPN) in patients suffering from MalnutritionInflammation Complex Syndrome (MICS) on nutritional status, inflammation, adipocytokines and serum lipids. Subjects: Six patients with MICS were assigned to IDPN, whereas six patients matched for age, sex, body mass index (BMI) and co-morbidity without malnutrition served as controls. Patients were recruited from Outpatient Dialysis Unit, Medical University Innsbruck and from Dialysis Unit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0
4

Year Published

2010
2010
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 43 publications
(52 reference statements)
0
9
0
4
Order By: Relevance
“…Improvements in overall protein balance improved in a randomized cross over study of 8 patients over 14 days [51] and also in another study which was open labeled and not controlled in 16 patients over 3 months [52]. The use of intradialytic parenteral nutrition (IDPN) solution in HD patients has also only been conducted in small studies, showing improvements in hepatic albumin synthesis and whole body fat free mass [53,54,55,56,57]. In the cross over study of 8 patients using both IDPN and oral supplements, the oral administration resulted in persistent anabolic benefits in the post dialysis phase, which was not seen with IDPN [55].…”
Section: Resultsmentioning
confidence: 99%
“…Improvements in overall protein balance improved in a randomized cross over study of 8 patients over 14 days [51] and also in another study which was open labeled and not controlled in 16 patients over 3 months [52]. The use of intradialytic parenteral nutrition (IDPN) solution in HD patients has also only been conducted in small studies, showing improvements in hepatic albumin synthesis and whole body fat free mass [53,54,55,56,57]. In the cross over study of 8 patients using both IDPN and oral supplements, the oral administration resulted in persistent anabolic benefits in the post dialysis phase, which was not seen with IDPN [55].…”
Section: Resultsmentioning
confidence: 99%
“…IDPN refers to PN delivered during the hemodialysis procedure, typically by administering the nutrient admixture through the venous drip chamber of the dialysis circuit 4 . ‐ 7 The majority of the published data include patients with CKD receiving intermittent hemodialysis, although limited data exist for patients on peritoneal dialysis receiving dialysates enriched with amino acids 8 . ‐ 19 IDPN typically provides 500–1000 kcal and 50–100 g of amino acids in less than 1 L of volume per dialysis treatment.…”
Section: Question 7: In Which Patients Is Intradialytic Pn a Reasonabmentioning
confidence: 99%
“…Published data suggest that IDPN is generally safe and effective in improving nonfluid weight gain over time 8 . ‐ 17 However, these studies generally suffer from a few common limitations: the sample sizes in most reports are small (less than 30 patients); the frequency and intensity of hemodialysis are not described or standardized; and oral nutrient intake is not controlled and often not monitored.…”
Section: Question 7: In Which Patients Is Intradialytic Pn a Reasonabmentioning
confidence: 99%
“…It turned out that used supplementation caused the increase in BMI but did not significantly affect albumin concentration. Moreover, a decreased TNF-α secretion and slightly increased IL-6 level were observed [25].…”
Section: Resultsmentioning
confidence: 99%
“…Joannidis et al [25] assessed the effect of 6-month supplementation with nutrient preparations (Aminomel Nephro, Elolipid, L-carnitine and vitamin E) on the nutritional status and inflammatory parameters in patients treated with haemodialysis. It turned out that used supplementation caused the increase in BMI but did not significantly affect albumin concentration.…”
Section: Resultsmentioning
confidence: 99%